Manejo de Taquicardia en el Embarazo

Evaluación Inicial

• Las arritmias, especialmente las taquiarritmias supraventriculares, son más frecuentes durante el embarazo y pueden manifestarse por primera vez en este período 1, 2
• Es esencial determinar si hay enfermedad cardíaca estructural subyacente mediante ecocardiograma, especialmente en pacientes con arritmias documentadas 3
• La evaluación debe incluir monitoreo Holter si los síntomas persisten para detectar arritmias 3

Algoritmo de Tratamiento para Taquicardias Supraventriculares

• El manejo de la taquicardia durante el embarazo debe seguir un enfoque escalonado comenzando con maniobras vagales, seguido por adenosina intravenosa si las maniobras vagales fallan, y metoprolol intravenoso si la adenosina no es efectiva para terminar la taquicardia 1, 4
• En caso de taquicardia con inestabilidad hemodinámica, realizar cardioversión eléctrica inmediata 1, 4, 5
• En caso de taquicardia con estabilidad hemodinámica, iniciar con maniobras vagales, seguido por adenosina intravenosa si fallan las maniobras vagales, y metoprolol intravenoso si la adenosina falla 1, 4

Manejo Específico por Tipo de Taquicardia

• Para el control de frecuencia en taquicardia auricular focal, se recomienda el uso de betabloqueantes y/o digitálicos para evitar cardiomiopatía inducida por taquicardia 1, 4
• En pacientes con taquicardia auricular focal y síntomas definidos, se puede considerar terapia antiarrítmica profiláctica con flecainida, propafenona o sotalol 1, 4
• La cardioversión eléctrica generalmente no se recomienda para taquicardia auricular focal debido a la recurrencia de la taquicardia 1, 4
• Aproximadamente 30% de las taquicardias auriculares pueden terminarse con adenosina 1, 4
• La ablación con catéter debe considerarse en casos resistentes a fármacos y mal tolerados de taquicardia auricular focal 1, 4

Consideraciones Especiales

• La amiodarona debe usarse solo cuando otras terapias han fallado y a la dosis efectiva más baja, debido a sus efectos fetotóxicos 1, 4, 5
• La ablación con catéter debe considerarse solo en casos especiales si es necesario durante el embarazo 1, 4
• El seguimiento regular debe realizarse para monitorear tanto los síntomas maternos como el bienestar fetal 3

Manejo de Taquicardia en el Embarazo

Evaluación Inicial

• Las arritmias que requieren tratamiento se desarrollan en hasta el 15% (media 5%) de pacientes con cardiopatías congénitas durante el embarazo 6
• Los episodios de taquicardia sostenida, particularmente el aleteo auricular, no son bien tolerados y pueden causar hipoperfusión fetal en cardiopatías estructurales 6

Algoritmo de Tratamiento según Estabilidad Hemodinámica

• La terapia antiarrítmica profiláctica debe usarse solo si los síntomas son intolerables o si la taquicardia causa compromiso hemodinámico 6
• Primera línea: digoxina o betabloqueante selectivo (metoprolol) 6
• Segunda línea: sotalol, flecainida o propafenona 6
• No usar bloqueadores del nodo AV en pacientes con preexcitación manifiesta en el ECG en reposo 6

Manejo Específico por Tipo de Taquicardia

• Aproximadamente 30% de las taquicardias auriculares pueden terminarse con adenosina 7
• La ablación con catéter debe considerarse en casos resistentes a fármacos y mal tolerados 7
• Son muy raros durante el embarazo a menos que exista cardiopatía estructural o hipertiroidismo 7
• En caso de inestabilidad hemodinámica, realizar cardioversión eléctrica 7
• Se recomienda anticoagulación terapéutica con HBPM o antagonistas de vitamina K según la etapa del embarazo para pacientes con fibrilación auricular 8
• En pacientes con antecedentes personales o familiares de muerte súbita, se recomienda vigilancia estrecha con investigación inmediata si se reportan síntomas de palpitaciones o presíncope 8

Consideraciones Especiales

• La amiodarona debe usarse solo cuando otras terapias han fallado y a la dosis efectiva más baja, debido a sus efectos fetotóxicos 6

Management of Tachycardia in Pregnancy

Immediate Assessment and Stabilization

• If hemodynamically unstable, the American Heart Association recommends immediate electrical cardioversion using the same protocol as non-pregnant patients with biphasic shock energy of 120-200 J 9, 10
• Cardioversion is not contraindicated in pregnancy and should be used for any sustained tachycardia causing hemodynamic instability that threatens fetal security, according to the European Heart Journal 11, 9
• The European Heart Journal suggests that the lateral defibrillator pad should be placed under the breast tissue 9

Critical Differential Diagnoses to Rule Out

• Peripartum cardiomyopathy can present with new-onset ventricular tachycardia during the last 6 weeks of pregnancy or postpartum, as stated by the European Heart Journal 12
• Thyroid storm, which can precipitate atrial fibrillation or flutter, presents with tachycardia, diaphoresis, and dyspnea, according to the European Heart Journal 12

Essential Diagnostic Workup

• Continuous fetal monitoring is essential to assess fetal heart rate and well-being, as maternal arrhythmias can cause fetal hypoperfusion, as recommended by the European Heart Journal 11

Long-Term Management and Prophylaxis

• The European Heart Journal recommends cardioselective beta-blockers (metoprolol or propranolol) as first-line for preventing recurrent supraventricular tachycardia 11, 10
• Beta-blockers should be used with caution in the first trimester but are generally safe thereafter, according to the European Heart Journal 10

Special Considerations for Pregnancy

• The European Heart Journal states that drug levels need to be monitored more carefully during pregnancy as pharmacokinetics are altered 11
• If gentamicin is required, levels must be checked with particular care due to risk of fetal deafness, as recommended by the European Heart Journal 11

Critical Pitfalls to Avoid

• The American Heart Association and the European Heart Journal emphasize that cardioversion should not be delayed in hemodynamically unstable patients due to concerns about pregnancy; maternal stability is essential for fetal survival 9, 10
• The European Heart Journal warns that AV nodal blockers (adenosine, beta-blockers, calcium channel blockers) should not be used in patients with manifest pre-excitation on ECG as this can precipitate ventricular fibrillation 10

Management of Tachycardia in Pregnancy

Immediate Assessment and Stabilization

• The European Society of Cardiology recommends immediate electrical cardioversion if a patient demonstrates hemodynamic instability, while stable patients should undergo urgent cardiac evaluation with ECG, continuous monitoring, and echocardiography to identify the arrhythmia type and guide treatment 13
• If hemodynamically unstable, the European Heart Journal suggests performing immediate electrical cardioversion using biphasic shock energy of 120-200 J with the lateral defibrillator pad placed under the breast tissue, as maternal stability is essential for fetal survival and cardioversion should never be delayed due to pregnancy concerns 13

Treatment Algorithm Based on Arrhythmia Type

For Supraventricular Tachycardia

• The European Heart Journal recommends vagal maneuvers as the first-line treatment for acute conversion in stable patients with supraventricular tachycardia 13
• If vagal maneuvers fail, the European Heart Journal suggests using IV adenosine as the second-line treatment, which is safe and effective in pregnancy 13
• The European Heart Journal recommends oral metoprolol or propranolol as the first-line treatment for long-term prophylaxis for recurrent SVT, as cardioselective beta-blockers are safe after the first trimester 13
• The European Heart Journal advises against using atenolol for any arrhythmia in pregnancy 13

Special Pregnancy Considerations

• The European Heart Journal recommends left lateral decubitus positioning for symptomatic bradycardia or hypotension to relieve inferior vena cava compression 13

Approach to Maternal Tachycardia

Diagnostic and Treatment Considerations

• The American Heart Association recommends attempting vagal maneuvers first, such as Valsalva, carotid massage, or ice-cold wet towel to face, for stable supraventricular tachycardia (SVT) in pregnant patients 14
• If vagal maneuvers fail, the American College of Cardiology suggests giving IV adenosine 6 mg rapid push, followed by up to two 12 mg doses if ineffective, as it is safe in pregnancy with a short half-life preventing fetal exposure 14
• The American Heart Association recommends using IV metoprolol or propranolol as a slow infusion to minimize hypotension if adenosine fails, as beta-blockers have extensive safety data over decades in pregnancy 14
• IV verapamil may be used if adenosine and beta-blockers fail or are contraindicated, but it carries a higher risk of maternal hypotension than adenosine 14

Management of Tachycardia in Pregnancy

Immediate Stabilization Based on Hemodynamic Status

Acute Management of Hemodynamically Stable Supraventricular Tachycardia (SVT)

Long‑Term Prophylaxis for Recurrent or Symptomatic SVT

Management of Atrial Fibrillation/Flutter

Management of Ventricular Tachycardia (VT)

Essential Diagnostic Workup

Medications Absolutely Contraindicated in Pregnancy

Special Considerations for Catheter Ablation

Monitoring and Follow‑Up

Pharmacologic Management of Inappropriate Sinus Tachycardia in Pregnancy

Second‑line Therapy

• Digoxin may be employed for rate control in pregnant patients with inappropriate sinus tachycardia when first‑line cardioselective β‑blockers are inadequate, although it is frequently ineffective for preventing arrhythmia. 16

Contraindicated Medications

• Amiodarone should be reserved only for absolute last‑resort use at the lowest effective dose in pregnancy because of documented fetotoxic effects, including fetal thyroid dysfunction, growth restriction, and possible neurodevelopmental impairment. 16